header

2014

Veröffentlichungen 2014

Zeitschriftenartikel

W. Schneider: Begutachtung bei psychischen und psychosomatischen Erkrankungen: Leitfaden für die Bewertung der beruflichen Leistungsfähigkeit. Neuro aktuell, 2, 2014, 28-32 

W. Schneider: Psychische Gesundheit und Arbeit. Editorial ASU Arbeitsmedizin Sozialmedizin Umweltmedizin, 7, 2014, 480-481 

W. Schneider: Editorial RPR Recht & Praxis der Rehabilitation, 3 2014 2-3 

W. Schneider, T. Braungardt, J. Schmiedeberg: Ist die vielfach diskutierte Zunahme der psychischen Erkrankungen ein Ausdruck der Medikalisierung sozialer Probleme? RPR Recht & Praxis der Rehabilitation, 3, 2014 5-14 

W. Schneider: Ein systematischer Ansatz zur Beurteilung/ Begutachtung der beruflichen Leistungsfähigkeit. RPR, Recht & Praxis der Rehabilitation, 3, 2014, 53 - 57

Freyberger, H. J., Schneider, W.: Relevanz der Diagnostik in der Psychotherapie. Psychotherapeut, 59, 6 2014, 437-438 

Schneider, W. und H.J. Freyberger: Diagnostik in der Psychotherapie. Psychotherapeut, 59, 6 2014, 439-447 

Frances, A.- Übersetzung Schneider, W. -: DSM und die Psychotherapie. Psychotherapeut, 59, 6 2014, 461-463 

Schneider, W.: Preventing overdiagnosis. Psychotherapeut, 59, 6 2014, 464-466

*Teipel SJ, Thyrian JR, Hertel J, Eichler T, Wucherer D, Michalowsky B, Kilimann I, Hoffmann W. Neuropsychiatric symptoms in people screened positive for dementia in primary care. Int Psychogeriatr. 2015, 27(1): 39-48 (IF 1,89)

Eichler T Wucherer D, Thyrian JR, Kilimann I, Hertel J, Michalowsky B, Teipel SJ, Hoffmann W. Antipsychotic Drug Treatment in Ambulatory Dementia Care: Prevalence and Correlates. J Alzheimers Dis, 2015, 43(4): 1303-11 (IF 4,17)

Kasper E, Schuster C, Machts J, Kaufmann J, Bittner D, Vielhaber S, Benecke R, Teipel SJ, Prudlo J. Microstructural white matter changes underlying cognitive and behavioural impairment in ALS – an in vivo study using DTI. PloS One, 2014, 9(12):e114543 (IF 4,09)

Wucherer D, Eichler T, Kilimann I, Hertel J, Michalowsky B, Thyrian JR, Teipel SJ, Hoffmann W. Antidementia Drug Treatment in people screened positive for dementia in primary care. J Alzheimers Dis, 2014, epub ahead of print (IF 4,17)

*Teipel SJ, Ehlers I, Erbe A, Holzmann C, Lau E, Hauenstein K, Berger C. Structural Connectivity changes underlying altered working memory networks in mild cognitive impairment: a three-way image fusion analysis. J Neuroimaging, 2014, epub ahead of print (IF 1,82)

Berger C, Erbe A, Ehlers I, Marx I, Hauenstein K, Teipel SJ. Effects of task-irrelevant emotional stimuli on working memory processes in MCI. J Alzheimers Dis, 2014, epub ahead of print (IF 4,17)

Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel SJ, Lieb K, Tüscher O, Fellgiebel A. Increased CSF APPs-ß levels in patients with Alzheimer disease treated with acitretin. J Neurol, 2014, 83(21): 1930-5 (IF 3,58)

Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehéricy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel SJ, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M; EADC -European Alzheimer's Disease Consortium and the ADNI - Alzheimer's Disease Neuroimaging Initiative. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimers Dement. 2014, epub ahead of print (IF14,48)

Kilimann I, Ovari A, Hermann A, Witt G, Pau HW, Teipel SJ. Hearing impairment and dementia. Z  Gerontol Geriatr, 2014, epub ahead of print (IF 1,02)

Grothe M, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J. Neurol. 2014, 261(10): 1939-48 (IF 3,58)

Schuster C, Kasper E, Machts J, Bittner D, Kaufmann J, Benecke R, Teipel SJ, Vielhaber S, Prudlo J. Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis. Journal of Neurology. 2014, 261(10): 1871-80 (IF 3,58)

*Teipel SJ, Lerche M, Kilimann I, O’Brien K, Grothe M, Meyer P, Li X, Sänger P, Hauenstein KH. Decline of fiber tract integrity over the adult age range – a diffusion spectrum imaging study. J Magn Reson Imaging. 2014, 40(2): 348-59 (IF 2,57)

Eichler T, Thyrian RJ, Hertel J, Köhler L, Wucherer D, Dreier A, Michalowsky B, Teipel SJ, Hoffmann W. Rates of Formal diagnosis in People Screened Positive for Dementia in Primary Care: results of the DelpHi-Trial. J Alzheimers Dis., 2014, 42(2): 451-8 (IF 4,17)

Kljajevic V, Grothe MJ, Ewers M, Teipel SJ. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer:s disease. Neurobiol Aging, 2014, 35(9): 1973-81 (IF 6,17)

Morgen K, Ramirez A, Frölich L, Tost H, Plichta MM, Kölsch H, Ragebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Hampel H, Teipel SJ, Pantel J, Heuser I, Wiltfang J, Rüther E, Kornhuber J, Maier W, Meyer-Lindenberg A. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer’s disease. Alzheimers Dement, 2014, 10(5 Suppl): 269-76 (IF 14,48)

*Teipel SJ, Walter M, Likitjaroen Y, Schönknecht P, Gruber O. Diffusion tensor imaging in AD and affective disorders. Eur Arch Psych Clin Neurosci, 2014, epub ahead of print (IF 3,20)

*Teipel SJ,  Grothe MJ, Filippi M, Fellgiebel A, Dyrba M, Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K. Fractional Anisotropy Changes in AD Depend on the Underlying Fiber Tract Architecture: A Multiparametric DTI Study using Joint Independent Component Analysis. J Alzheimers Dis., 2014, 41(1): 69-83 (IF 4,17)

Kilimann I, Grothe M, Heinsen H, Alho EJ, Grinberg L, Amaro Jr E, Dos Santos GA, da Silva RE, Mitchell AJ, Frisoni GB, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Kloppel S, Teipel SJ; Subregional basal forebrain atrophy in Alzheimer's disease: A multicenter study. J Alzheimers Dis, 2014, 40(3): 687-700 (IF 4,17)

Petersen S, Zimmermann U, Schmidt C, Schwabe L, Warkentin M, Teipel SJ; Linking a neural mass model with a 3d model of the human brain to reproduce EEG signals. Biomed Tech (Berl), 2014, 59(3): 231-40 (IF 1,16)

*Teipel S, Heinsen H, Amaro E, Jr., Grinberg LT, Krause B, Grothe M, Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease. Neurobiol Aging, 2014, 35(3):482-9 (IF 6,17)

Grothe MJ, Ewers M, Krause B, Heinsen H, Teipel SJ; Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects. Alzheimer’s Disease Neuroimaging Initiative, Alzheimers Dement, 2014, 10(5 Suppl): 344-53 (IF 14,48)

Kirste T, Hoffmeyer A, Koldrack P, Bauer A, Schubert S, Schröder S, Teipel SJ; Detecting the effect of Alzheimer’s disease on everyday motion behavior. J Alzheimers Dis, 2014, 38(1): 121-32 (IF 4,17)

Wolf D, Grothe M, Fischer FU, Heinsen H, Kilimann I, Teipel S, Fellgiebel A. Associaton of basal forebrain volumes and cognition in normal aging. Neuropsychologia, 2014, 53:54-63 (IF 4,37)

Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, Mitchell AJ, Benecke R, Teipel SJ, Vielhaber S, Prudlo J; Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiology of Aging 2014, 35(1): 240-6 (IF 6,17)

*Teipel SJ, Flatz W, Ackl N, Grothe M, Kilimann I, Bokde AL, Grinberg L, Amaro E Jr, Kljajevic V, Alho E, Knels C, Ebert A, Heinsen H, Danek A; Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala’s nucleus. J Psychiatr Res, 2014, 221(3): 187-94 (IF 4,07)

Hampel H, Lista S, Teipel SJ, Garaci F, Nistico R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardijan H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehericy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B. Perspective on future role of biological markers in clinical therapy trials of AD: a long-range point of view beyond 2020. Biochem Pharmacol, 2014, 88(4): 426-49 (IF 6,17)

Kasper E, Wegrzyn M, Marx I, Korp C, Kress W, Benecke R, Teipel SJ, Prudlo J. Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy’s disease. Amyotroph Lateral Scler Frontotemporal Degener, 2014, 15(1-2): 15-20 (IF 3,09)

Kljajevic V, Meyer P, Holzmann C, Dyrba M, Kasper E, Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel SJ; EDSD study group. The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease. Alzheimers Dement. 2014, 10(3): 401-404 (IF 14,48)

Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H. CSF Aß-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer’s disease. Alzheimers Dement., 2014, 10(3): 381-392 (IF 14,48)

Doblhammer G, Fritze T, Teipel S. Regional Patterns of Dementia in Germany and Their Relationship with Chronic Disease, CPoS, 2014, Special Issue (IF -)

Buchbeiträge

W. Schneider: Die Professionalisierung der Arbeitsmedizin für psychosoziale Aufgaben. In D. Windemuth, D. Jung, O. Petermann (Hrsg.): Psychische Erkrankungen im Betrieb – Eine Orientierungshilfe für die Praxis. Universum Verlag, Wiesbaden, 2014 (400 – 426) 

W. Schneider: Zerstörung als Ausweg. In Freyberger, H. J., Dilling, H. (Hrsg.): Fallbuch Psychiatrie Kasuistik zum Kapitel V(F) der ICD-10. Huber, Bern, 2014 (69-78)

Diagnostisches und Statistisches Manual Psychischer Störungen DSM-5. Herausgeber: Falkai P, Wittchen H-U, Kapitel: Neurokognitive Störungen (NCD), Jessen F, Teipel S, Wagner M, Zihl J, Hogrefe, 2014, S 811-881

Health among the elderly in Germany, New evidence on disease, disability and care need. Editor: Doblhammer G, Spatial patterns of dementia prevalence and its vascular risk factors in Germany; Doblhammer G, Fritze T, Teipel S. Bundesinstitut für Bevölkerungsforschung, Vol. 46, 2014, pp 51-67

Grothe M, Kurth J, Hampel H, Krause B, Teipel S. Standardization of MRI and Amyloid Imaging, in: Bairu M, Weiner M (Eds.), Global Clinical Trials for Alzheimer's Disease: Design, Implementation, and Standardization. Academic Press (Elsevier) 2014, pp. 131-156

Grothe MJ, Bokde ALW, Teipel SJ. Functional and Structural MRI in Alzheimer’s Disease: A Multimodal Approach, in: Mulert C, Shenton ME (Eds.), MRI in Psychiatry. Springer Berlin Heidelberg 2014 (in press)

Gedächtnisstörungen, Diagnostik und Rehabilitation, Autoren: Bartsch Th, Falkai P (Hrsg), Kapitel 18: Alzheimer Krankheit;  Autoren: Teipel SJ, Kilimann I, Springer Verlag 2014, Seite 239-262

1.      Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, Jack CR Jr, Sperling R, Cummings J, Blennow K, O’Bryant S, Frisoni GB, Khachaturian A, Kivipelto M, Klunk W, Broich K, Andrieu S, de Schotten MT, Mangin JF, Lammertsma AA, Johnson K, Teipel SJ, Drzezga A, Bokde A, Colliot O, Bakardijan H, Zetterberg H, Dubois B, Vellas B, Schneider LS, Hampel H. The Road Ahead to Cure Alzheimer’s Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. J Prev Alzheimers Dis, 2014, 1(3): 181-202 (IF )

 

2.      Kasper E, Schuster C, Machts J, Kaufmann J, Bittner D, Vielhaber S, Benecke R, Teipel SJ, Prudlo J. Microstructural white matter changes underlying cognitive and behavioural impairment in ALS – an in vivo study using DTI. PloS One, 2014, 9(12):e114543 (IF 4,09)

 

3.      Teipel SJ, Ehlers I, Erbe A, Holzmann C, Lau E, Hauenstein K, Berger C. Structural Connectivity changes underlying altered working memory networks in mild cognitive impairment: a three-way image fusion analysis. J Neuroimaging, 2014, e-pub ahead of print (IF 1,82)

 

4.      Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel SJ, Lieb K, Tüscher O, Fellgiebel A. Increased CSF APPs-ß levels in patients with Alzheimer disease treated with acitretin. J Neurol, 2014, 83(21): 1930-5 (IF 3,58)

 

5.      Grothe M, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J. Neurol. 2014, 261(10): 1939-48 (IF 3,58)

 

6.      Schuster C, Kasper E, Machts J, Bittner D, Kaufmann J, Benecke R, Teipel SJ, Vielhaber S, Prudlo J. Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis. Journal of Neurology. 2014, 261(10): 1871-80 (IF 3,58)

 

7.      *Teipel SJ, Lerche M, Kilimann I, O’Brien K, Grothe M, Meyer P, Li X, Sänger P, Hauenstein KH. Decline of fiber tract integrity over the adult age range – a diffusion spectrum imaging study. J Magn Reson Imaging. 2014, 40(2): 348-59 (IF 2,57)

 

8.      Eichler T, Thyrian RJ, Hertel J, Köhler L, Wucherer D, Dreier A, Michalowsky B, Teipel SJ, Hoffmann W. Rates of Formal diagnosis in People Screened Positive for Dementia in Primary Care: results of the DelpHi-Trial. J Alzheimers Dis., 2014, 42(2): 451-8 (IF 4,17)

 

9.      Kljajevic V, Grothe MJ, Ewers M, Teipel SJ. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer:s disease. Neurobiol Aging, 2014, 35(9): 1973-81 (IF 6,17)

 

10.    Morgen K, Ramirez A, Frölich L, Tost H, Plichta MM, Kölsch H, Ragebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Hampel H, Teipel SJ, Pantel J, Heuser I, Wiltfang J, Rüther E, Kornhuber J, Maier W, Meyer-Lindenberg A. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer’s disease. Alzheimers Dement, 2014, 10(5 Suppl): 269-76 (IF 14,48)

 

11.    *Teipel SJ, Walter M, Likitjaroen Y, Schönknecht P, Gruber O. Diffusion tensor imaging in AD and affective disorders. Eur Arch Psych Clin Neurosci, 2014, epub ahead of print (IF 3,20)

 

12.    *Teipel SJ,  Grothe MJ, Filippi M, Fellgiebel A, Dyrba M, Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K. Fractional Anisotropy Changes in AD Depend on the Underlying Fiber Tract Architecture: A Multiparametric DTI Study using Joint Independent Component Analysis. J Alzheimers Dis., 2014, 41(1): 69-83 (IF 4,17)

 

13.    Kilimann I, Grothe M, Heinsen H, Alho EJ, Grinberg L, Amaro Jr E, Dos Santos GA, da Silva RE, Mitchell AJ, Frisoni GB, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Kloppel S, Teipel SJ; Subregional basal forebrain atrophy in Alzheimer's disease: A multicenter study. J Alzheimers Dis, 2014, 40(3): 687-700 (IF 4,17)

 

14.    Petersen S, Zimmermann U, Schmidt C, Schwabe L, Warkentin M, Teipel SJ; Linking a neural mass model with a 3d model of the human brain to reproduce EEG signals. Biomed Tech (Berl), 2014, 59(3): 231-40 (IF 1,16)

 

15.    *Teipel S, Heinsen H, Amaro E, Jr., Grinberg LT, Krause B, Grothe M, Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease. Neurobiol Aging, 2014, 35(3):482-9 (IF 6,17)

 

16.    Grothe MJ, Ewers M, Krause B, Heinsen H, Teipel SJ; Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects. Alzheimer’s Disease Neuroimaging Initiative, Alzheimers Dement, 2014, 10(5 Suppl): 344-53 (IF 14,48)

 

17.    Kirste T, Hoffmeyer A, Koldrack P, Bauer A, Schubert S, Schröder S, Teipel SJ; Detecting the effect of Alzheimer’s disease on everyday motion behavior. J Alzheimers Dis, 2014, 38(1): 121-32 (IF 4,17)

 

18.    Wolf D, Grothe M, Fischer FU, Heinsen H, Kilimann I, Teipel S, Fellgiebel A. Association of basal forebrain volumes and cognition in normal aging. Neuropsychologia, 2014, 53:54-63 (IF 4,37)

 

19.    Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, Mitchell AJ, Benecke R, Teipel SJ, Vielhaber S, Prudlo J; Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiology of Aging 2014, 35(1): 240-6 (IF 6,17)

 

20.    *Teipel SJ, Flatz W, Ackl N, Grothe M, Kilimann I, Bokde AL, Grinberg L, Amaro E Jr, Kljajevic V, Alho E, Knels C, Ebert A, Heinsen H, Danek A; Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala’s nucleus. J Psychiatr Res, 2014, 221(3): 187-94 (IF 4,07)

 

21.    Hampel H, Lista S, Teipel SJ, Garaci F, Nistico R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardijan H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehericy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B. Perspective on future role of biological markers in clinical therapy trials of AD: a long-range point of view beyond 2020. Biochem Pharmacol, 2014, 88(4): 426-49 (IF 6,17)

 

22.    Kasper E, Wegrzyn M, Marx I, Korp C, Kress W, Benecke R, Teipel SJ, Prudlo J. Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy’s disease. Amyotroph Lateral Scler Frontotemporal Degener, 2014, 15(1-2): 15-20 (IF 3,09)

 

23.    Kljajevic V, Meyer P, Holzmann C, Dyrba M, Kasper E, Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel SJ; EDSD study group. The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease. Alzheimers Dement. 2014, 10(3): 401-404 (IF 14,48)

 

24.    Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H. CSF Aß-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer’s disease. Alzheimers Dement., 2014, 10(3): 381-392 (IF 14,48)

 

25.    Doblhammer G, Fritze T, Teipel S. Regional Patterns of Dementia in Germany and Their Relationship with Chronic Disease, CPoS, 2014, Special Issue (IF -)